Original language | English |
---|---|
Pages (from-to) | 4 |
Number of pages | 1 |
Journal | Acta neuropathologica communications |
Volume | 6 |
Issue number | 1 |
DOIs | |
Publication status | Published - Jan 4 2018 |
Externally published | Yes |
ASJC Scopus Subject Areas
- Clinical Neurology
- Cellular and Molecular Neuroscience
- Pathology and Forensic Medicine
Keywords
- Experimental autoimmune encephalomyelitis
- Lysolecithin
- Multiple sclerosis
- Proteoglycan
- Surfen
Fingerprint
Dive into the research topics of 'Surfen, a proteoglycan binding agent, reduces inflammation but inhibits remyelination in murine models of Multiple Sclerosis'. Together they form a unique fingerprint.Cite this
Warford, J. R., Lamport, A. C., Clements, D. R., Malone, A., Kennedy, B. E., Kim, Y., Gujar, S. A., Hoskin, D. W., & Easton, A. S. (2018). Surfen, a proteoglycan binding agent, reduces inflammation but inhibits remyelination in murine models of Multiple Sclerosis. Acta neuropathologica communications, 6(1), 4. https://doi.org/10.1186/s40478-017-0506-9